申请人:EnVivo Pharmaceuticals, Inc.
公开号:US20140364641A1
公开(公告)日:2014-12-11
Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described.
本文描述了作为γ-分泌酶调节剂的四取代苯,并且它们在治疗神经退行性疾病的一个或多个症状,例如阿尔茨海默病中的使用。